Giardiasis

1. Nakao JH, Collier SA, Gargano JW. Giardiasis and subsequent irritable bowel syndrome: a longitudinal cohort study using health insurance data. J Infect Dis. 2017 Mar 1. 215(5):798-805. [QxMD MEDLINE Link].

2. Beer KD, Collier SA, Du F, Gargano JW. Giardiasis diagnosis and treatment practices among commercially insured persons in the United States. Clin Infect Dis. 2017 May 1. 64(9):1244-50. [QxMD MEDLINE Link].

3. Daly ER, Roy SJ, Blaney DD, et al. Outbreak of giardiasis associated with a community drinking-water source. Epidemiol Infect. 2010 Apr. 138(4):491-500. [QxMD MEDLINE Link].

4. Robertson L, Gjerde B, Hansen EF, Stachurska-Hagen T. A water contamination incident in Oslo, Norway during October 2007; a basis for discussion of boil-water notices and the potential for post-treatment contamination of drinking water supplies. J Water Health. 2009 Mar. 7(1):55-66. [QxMD MEDLINE Link].

5. Eisenstein L, Bodager D, Ginzl D. Outbreak of giardiasis and cryptosporidiosis associated with a neighborhood interactive water fountain--Florida, 2006. J Environ Health. 2008 Oct. 71(3):18-22; quiz 49-50. [QxMD MEDLINE Link].

6. Nishi L, Baesso ML, Santana RG, Fregadolli P, Falavigna DL, Falavigna-Guilherme AL. Investigation of Cryptosporidium spp. and Giardia spp. in a public water-treatment system. Zoonoses Public Health. 2009 Jun. 56(5):221-8. [QxMD MEDLINE Link].

7. Escobedo AA, Almirall P, Gonzalez-Fraile E, Ballesteros J. Efficacy of mebendazole in paediatric patients with giardiasis: a systematic review and meta-analysis. Acta Trop. 2018 Aug 6. 188:50-7. [QxMD MEDLINE Link].

8. Hill DR. Giardia lamblia. Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 2. 6th ed. Philadelphia, Pennsylvania: Churchill Livingstone An Imprint of Elsevier Inc.; 2005. 277: 3198-3203.

9. Huston CD. Intestinal protozoa. Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th ed. Philadelphia, PA: Saunders; 2006. Vol 2: 2420-3.

10. Robertson LJ, Forberg T, Gjerde BK. Giardia cysts in sewage influent in Bergen, Norway 15-23 months after an extensive waterborne outbreak of giardiasis. J Appl Microbiol. 2008 Apr. 104(4):1147-52. [QxMD MEDLINE Link].

11. Ryu H, Alum A, Mena KD, Abbaszadegan M. Assessment of the risk of infection by Cryptosporidium and Giardia in non-potable reclaimed water. Water Sci Technol. 2007. 55(1-2):283-90. [QxMD MEDLINE Link].

12. Farthing MJ. Giardiasis. Gastroenterol Clin North Am. 1996 Sep. 25(3):493-515. [QxMD MEDLINE Link].

13. Sears CL. Giardiasis. Giardiasis. Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders; 2007. 2402-4.

14. Monis PT, Thompson RC. Cryptosporidium and Giardia-zoonoses: fact or fiction?. Infect Genet Evol. 2003 Nov. 3(4):233-44. [QxMD MEDLINE Link].

15. Huang DB, White AC. An updated review on Cryptosporidium and Giardia. Gastroenterol Clin North Am. 2006 Jun. 35(2):291-314, viii. [QxMD MEDLINE Link].

16. Thompson RC, Palmer CS, O'Handley R. The public health and clinical significance of Giardia and Cryptosporidium in domestic animals. Vet J. 2008 Jul. 177(1):18-25. [QxMD MEDLINE Link].

17. Ballweber LR, Xiao L, Bowman DD, Kahn G, Cama VA. Giardiasis in dogs and cats: update on epidemiology and public health significance. Trends Parasitol. 2010 Apr. 26(4):180-9. [QxMD MEDLINE Link].

18. John CC. Giardiasis and balantidiasis. Kliegman RM, Behrman BE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: Saunders; 2007. 1462-4.

19. Leung AKC, Leung AAM, Wong AHC, Sergi CM, Kam JKM. Giardiasis: an overview. Recent Pat Inflamm Allergy Drug Discov. 2019. 13(2):134-43. [QxMD MEDLINE Link]. [Full Text].

20. Adam RD. Biology of Giardia lamblia. Clin Microbiol Rev. 2001 Jul. 14(3):447-75. [QxMD MEDLINE Link]. [Full Text].

21. Dixon BR. Giardia duodenalis in humans and animals - transmission and disease. Res Vet Sci. 2021 Mar. 135:283-9. [QxMD MEDLINE Link].

22. Waldram A, Vivancos R, Hartley C, Lamden K. Prevalence of Giardia infection in households of Giardia cases and risk factors for household transmission. BMC Infect Dis. 2017 Jul 11. 17(1):486. [QxMD MEDLINE Link]. [Full Text].

23. Lopez CE, Dykes AC, Juranek DD, et al. Waterborne giardiasis: a communitywide outbreak of disease and a high rate of asymptomatic infection. Am J Epidemiol. 1980 Oct. 112(4):495-507. [QxMD MEDLINE Link].

24. Buret AG. Mechanisms of epithelial dysfunction in giardiasis. Gut. 2007 Mar. 56(3):316-7. [QxMD MEDLINE Link]. [Full Text].

25. Hill DR. Giardiasis. Issues in diagnosis and management. Infect Dis Clin North Am. 1993 Sep. 7(3):503-25. [QxMD MEDLINE Link].

26. Hanevik K, Hausken T, Morken MH, et al. Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection. J Infect. 2007 Dec. 55(6):524-30. [QxMD MEDLINE Link].

27. Buret AG. Pathophysiology of enteric infections with Giardia duodenalius. Parasite. 2008 Sep. 15(3):261-5. [QxMD MEDLINE Link].

28. Faubert G. Immune response to Giardia duodenalis. Clin Microbiol Rev. 2000 Jan. 13(1):35-54. [QxMD MEDLINE Link]. [Full Text].

29. Liu J, Ma'ayeh S, Peirasmaki D, Lundstrom-Stadelmann B, Hellman L, Svard SG. Secreted Giardia intestinalis cysteine proteases disrupt intestinal epithelial cell junctional complexes and degrade chemokines. Virulence. 2018 Dec 31. 9 (1):879-94. [QxMD MEDLINE Link].

30. Buret AG. Immunopathology of giardiasis: the role of lymphocytes in intestinal epithelial injury and malfunction. Mem Inst Oswaldo Cruz. 2005 Mar. 100 Suppl 1:185-90. [QxMD MEDLINE Link].

31. Garcia LS. Intestinal Protozoa: Flagellates and Ciliates. Diagnostic Medical Parasitology. 5th ed. Washington, D.C: ASM Press; 2007. 3: 36-49.

32. Roxstrom-Lindquist K, Palm D, Reiner D, Ringqvist E, Svard SG. Giardia immunity--an update. Trends Parasitol. 2006 Jan. 22(1):26-31. [QxMD MEDLINE Link].

33. Panaro MA, Cianciulli A, Mitolo V, et al. Caspase-dependent apoptosis of the HCT-8 epithelial cell line induced by the parasite Giardia intestinalis. FEMS Immunol Med Microbiol. 2007 Nov. 51(2):302-9. [QxMD MEDLINE Link].

34. Liu C, Crawford JM. The gastrointestinal tract. Kumar V, Abbas AK, Fausto N, eds. Robbins and Cotran: Pathologic Basis of Disease. 7th ed. Philadelphia: Saunders; 2004. 840. [Full Text].

35. Sprong H, Caccio SM, van der Giessen JW, ZOOPNET network and partners. Identification of zoonotic genotypes of Giardia duodenalis. PLoS Negl Trop Dis. 2009 Dec 1. 3(12):e558. [QxMD MEDLINE Link]. [Full Text].

36. Lebbad M, Petersson I, Karlsson L, et al. Multilocus genotyping of human Giardia isolates suggests limited zoonotic transmission and association between assemblage B and flatulence in children. PLoS Negl Trop Dis. 2011 Aug. 5(8):e1262. [QxMD MEDLINE Link]. [Full Text].

37. Caccio SM, Ryan U. Molecular epidemiology of giardiasis. Mol Biochem Parasitol. 2008 Aug. 160(2):75-80. [QxMD MEDLINE Link].

38. Minvielle MC, Molina NB, Polverino D, Basualdo JA. First genotyping of Giardia lamblia from human and animal feces in Argentina, South America. Mem Inst Oswaldo Cruz. 2008 Feb. 103(1):98-103. [QxMD MEDLINE Link].

39. Robertson LJ, Forberg T, Hermansen L, Gjerde BK, Langeland N. Molecular characterisation of Giardia isolates from clinical infections following a waterborne outbreak. J Infect. 2007 Jul. 55(1):79-88. [QxMD MEDLINE Link].

40. Abdul-Wahid A, Faubert G. Characterization of the local immune response to cyst antigens during the acute and elimination phases of primary murine giardiasis. Int J Parasitol. 2008 May. 38(6):691-703. [QxMD MEDLINE Link].

41. Rendtorff RC. The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. Am J Hyg. 1954 Mar. 59(2):209-20. [QxMD MEDLINE Link].

42. Adam EA, Yoder JS, Gould LH, Hlavsa MC, Gargano JW. Giardiasis outbreaks in the United States, 1971-2011. Epidemiol Infect. 2016 Oct. 144(13):2790-801. [QxMD MEDLINE Link]. [Full Text].

43. Conners EE, Miller AD, Balachandran N, Robinson BM, Benedict KM. Giardiasis outbreaks - United States, 2012-2017. MMWR Morb Mortal Wkly Rep. 2021 Mar 5. 70(9):304-7. [QxMD MEDLINE Link]. [Full Text].

44. Dawson D. Foodborne protozoan parasites. Int J Food Microbiol. 2005 Aug 25. 103(2):207-27. [QxMD MEDLINE Link].

45. Fort GG, Mikolich DJ, Policar M. Giardiasis. Ferri FF, ed. Ferri's Clinical Advisor. Philadelphia, PA: Mosby; 2009. 358.

46. Yoder JS, Beach MJ. Giardiasis surveillance--United States, 2003-2005. MMWR Surveill Summ. 2007 Sep 7. 56(7):11-8. [QxMD MEDLINE Link].

47. Pickering LK, Woodward WE, DuPont HL, Sullivan P. Occurrence of Giardia lamblia in children in day care centers. J Pediatr. 1984 Apr. 104(4):522-6. [QxMD MEDLINE Link].

48. Pickering LK. Giardia lamblia (Giardiasis). Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Philadelphia, PA: Churchill Livingstone; 2008. 1241-5.

49. Caccio SM, Thompson RC, McLauchlin J, Smith HV. Unravelling Cryptosporidium and Giardia epidemiology. Trends Parasitol. 2005 Sep. 21(9):430-7. [QxMD MEDLINE Link].

50. Hajare ST, Chekol Y, Chauhan NM. Assessment of prevalence of Giardia lamblia infection and its associated factors among government elementary school children from Sidama zone, SNNPR, Ethiopia. PLoS One. 2022. 17(3):e0264812. [QxMD MEDLINE Link]. [Full Text].

51. Giangaspero A, Berrilli F, Brandonisio O. Giardia and Cryptosporidium and public health: the epidemiological scenario from the Italian perspective. Parasitol Res. 2007 Oct. 101(5):1169-82. [QxMD MEDLINE Link].

52. Laupland KB, Church DL. Population-based laboratory surveillance for Giardia sp. and Cryptosporidium sp. infections in a large Canadian health region. BMC Infect Dis. 2005 Sep 16. 5:72. [QxMD MEDLINE Link]. [Full Text].

53. Hoque ME. Giardiasis. Rakel RE, Bope ET, eds. Conn's Current Therapy. Philadelphia, PA: Saunders; 2008. 67/15.

54. Brodsky RE, Spencer HC Jr, Schultz MG. Giardiasis in American travelers to the Soviet Union. J Infect Dis. 1974 Sep. 130(3):319-23. [QxMD MEDLINE Link].

55. Dib HH, Lu SQ, Wen SF. Prevalence of Giardia lamblia with or without diarrhea in South East, South East Asia and the Far East. Parasitol Res. 2008 Jul. 103(2):239-51. [QxMD MEDLINE Link].

56. Gelanew T, Lalle M, Hailu A, Pozio E, Caccio SM. Molecular characterization of human isolates of Giardia duodenalis from Ethiopia. Acta Trop. 2007 May. 102(2):92-9. [QxMD MEDLINE Link].

57. Quihui L, Morales GG, Mendez RO, Leyva JG, Esparza J, Valencia ME. Could giardiasis be a risk factor for low zinc status in schoolchildren from northwestern Mexico? A cross-sectional study with longitudinal follow-up. BMC Public Health. 2010 Feb 20. 10(1):85. [QxMD MEDLINE Link]. [Full Text].

58. Thompson SC. Giardia lamblia in children and the child care setting: a review of the literature. J Paediatr Child Health. 1994 Jun. 30(3):202-9. [QxMD MEDLINE Link].

59. Escobedo AA, Almirall P, Alfonso M, Cimerman S, Rey S, Terry SL. Treatment of intestinal protozoan infections in children. Arch Dis Child. 2009 Jun. 94(6):478-82. [QxMD MEDLINE Link].

60. Jimenez JC, Pinon A, Dive D, Capron M, Dei-Cas E, Convit J. Antibody response in children infected with Giardia intestinalis before and after treatment with Secnidazole. Am J Trop Med Hyg. 2009 Jan. 80(1):11-5. [QxMD MEDLINE Link].

61. Dizdar V, Gilja OH, Hausken T. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron. Neurogastroenterol Motil. 2007 Dec. 19(12):977-82. [QxMD MEDLINE Link].

62. Penrose AS, Wells EV, Aiello AE. Infectious causation of chronic disease: examining the relationship between Giardia lamblia infection and irritable bowel syndrome. World J Gastroenterol. 2007 Sep 14. 13(34):4574-8. [QxMD MEDLINE Link].

63. Hanevik K, Dizdar V, Langeland N, Hausken T. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol. 2009 Apr 21. 9:27. [QxMD MEDLINE Link]. [Full Text].

64. Hanevik K, Wensaas KA, Rortveit G, et al. Irritable bowel syndrome and chronic fatigue 6 years after Giardia infection: a controlled prospective cohort study. Clin Infect Dis. 2014 Nov 15. 59(10):1394-400. [QxMD MEDLINE Link].

65. Ouattara M, N'guessan NA, Yapi A, N'goran EK. Prevalence and spatial distribution of Entamoeba histolytica/dispar and Giardia lamblia among schoolchildren in Agboville area (Côte d'Ivoire). PLoS Negl Trop Dis. 2010 Jan 19. 4(1):e574. [QxMD MEDLINE Link]. [Full Text].

66. Heyworth MF. Diagnostic testing for Giardia infections. Trans R Soc Trop Med Hyg. 2014 Mar. 108(3):123-5. [QxMD MEDLINE Link].

67. Nagaty IM, Hegazi MM. Dot-ELISA copro-antigen and direct stool examination in diagnosis of giardiasis patients. J Egypt Soc Parasitol. 2007 Aug. 37(2):641-8. [QxMD MEDLINE Link].

68. Strand EA, Robertson LJ, Hanevik K, Alvsvag JO, Morch K, Langeland N. Sensitivity of a Giardia antigen test in persistent giardiasis following an extensive outbreak. Clin Microbiol Infect. 2008 Nov. 14(11):1069-71. [QxMD MEDLINE Link].

69. Mayer CL, Palmer CJ. Evaluation of PCR, nested PCR, and fluorescent antibodies for detection of Giardia and Cryptosporidium species in wastewater. Appl Environ Microbiol. 1996 Jun. 62(6):2081-5. [QxMD MEDLINE Link].

70. Prasertbun R, Sukthana Y, Popruk S. Real-time PCR: benefits for detection of mild and asymptomatic Giardia infections. Trop Med Health. 2012 Jun. 40(2):31-5. [QxMD MEDLINE Link].

71. Youn S, Kabir M, Haque R, Petri WA Jr. Evaluation of a screening test for detection of giardia and cryptosporidium parasites. J Clin Microbiol. 2009 Feb. 47(2):451-2. [QxMD MEDLINE Link]. [Full Text].

72. Morken MH, Nysaeter G, Strand EA, Hausken T, Berstad A. Lactulose breath test results in patients with persistent abdominal symptoms following Giardia lamblia infection. Scand J Gastroenterol. 2008. 43(2):141-5. [QxMD MEDLINE Link].

73. Busatti HG, Santos JF, Gomes MA. The old and new therapeutic approaches to the treatment of giardiasis: where are we?. Biologics. 2009. 3:273-87. [QxMD MEDLINE Link]. [Full Text].

74. Busatti HG, Vieira AE, Viana JC, et al. Effect of metronidazole analogues on Giardia lamblia cultures. Parasitol Res. 2007 Dec. 102(1):145-9. [QxMD MEDLINE Link].

75. Monajemzadeh SM, Monajemzadeh M. Comparison of iron and hematological indices in Giardia lamblia infection before and after treatment in 102 children in Ahwaz, Iran. Med Sci Monit. 2008 Jan. 14(1):CR19-23. [QxMD MEDLINE Link].

76. Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev. 2001 Jan. 14(1):114-28. [QxMD MEDLINE Link]. [Full Text].

77. Petri WA. Treatment of giardiasis. Curr Treat Options Gastroenterol. 2005 Feb. 8(1):13-7. [QxMD MEDLINE Link].

78. Escobedo AA, Ballesteros J, Gonzalez-Fraile E, Almirall P. A meta-analysis of the efficacy of albendazole compared with tinidazole as treatments for Giardia infections in children. Acta Trop. 2016 Jan. 153:120-7. [QxMD MEDLINE Link].

79. Bourque DL, Neumayr A, Libman M, Chen LH. Treatment strategies for nitroimidazole-refractory giardiasis: a systematic review. J Travel Med. 2022 Jan 17. 29(1):taab120. [QxMD MEDLINE Link].

80. [Guideline] Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29. 65(12):e45-e80. [QxMD MEDLINE Link]. [Full Text].

81. Ordonez-Mena JM, McCarthy ND, Fanshawe TR. Comparative efficacy of drugs for treating giardiasis: a systematic update of the literature and network meta-analysis of randomized clinical trials. J Antimicrob Chemother. 2018 Mar 1. 73(3):596-606. [QxMD MEDLINE Link]. [Full Text].

82. Nabarro LE, Lever RA, Armstrong M, Chiodini PL. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013. Clin Microbiol Infect. 2015 Aug. 21(8):791-6. [QxMD MEDLINE Link].

83. Carter ER, Nabarro LE, Hedley L, Chiodini PL. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions. Clin Microbiol Infect. 2018 Jan. 24(1):37-42. [QxMD MEDLINE Link].

84. Ydsten KA, Hellgren U, Asgeirsson H. Quinacrine treatment of nitroimidazole-refractory giardiasis. J Infect Dis. 2022 May 16. 225(10):1773-6. [QxMD MEDLINE Link]. [Full Text].

85. van den Bijllaardt W, Overdevest IT, Buiting AG, Verweij JJ. Rapid clearance of Giardia lamblia DNA from the gut after successful treatment. Clin Microbiol Infect. 2014 Nov. 20(11):O972-4. [QxMD MEDLINE Link].

86. Kiser JD, Paulson CP, Brown C. Clinical inquiries. What's the most effective treatment for giardiasis?. J Fam Pract. 2008 Apr. 57(4):270-2. [QxMD MEDLINE Link].

87. Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev. 2001 Jan. 14(1):114-28. [QxMD MEDLINE Link].

88. Wright JM, Dunn LA, Upcroft P, Upcroft JA. Efficacy of antigiardial drugs. Expert Opin Drug Saf. 2003 Nov. 2(6):529-41. [QxMD MEDLINE Link].

89. Mahmud MA, Chappell CL, Hossain MM, Huang DB, Habib M, DuPont HL. Impact of breast-feeding on Giardia lamblia infections in Bilbeis, Egypt. Am J Trop Med Hyg. 2001 Sep. 65(3):257-60. [QxMD MEDLINE Link].

90. Escobedo AA, Cimerman S. Giardiasis: a pharmacotherapy review. Expert Opin Pharmacother. 2007 Aug. 8(12):1885-902. [QxMD MEDLINE Link].

91. Rayan P, Matthews B, McDonnell PA, Cock IE. Terminalia ferdinandiana extracts as inhibitors of Giardia duodenalis proliferation: a new treatment for giardiasis. Parasitol Res. 2015 Jul. 114(7):2611-20. [QxMD MEDLINE Link].

92. Lopez-Romero G, Quintero J, Astiazaran-Garcia H, Velazquez C. Host defences against Giardia lamblia. Parasite Immunol. 2015 Aug. 37(8):394-406. [QxMD MEDLINE Link].

93. Astiazaran-Garcia H, Inigo-Figueroa G, Quihui-Cota L, Anduro-Corona I. Crosstalk between zinc status and Giardia infection: a new approach. Nutrients. 2015 Jun 3. 7(6):4438-52. [QxMD MEDLINE Link].

94. Krumrie S, Capewell P, Smith-Palmer A, Mellor D, Weir W, Alexander CL. A scoping review of risk factors and transmission routes associated with human giardiasis outbreaks in high-income settings. Curr Res Parasitol Vector Borne Dis. 2022 Feb 21. 2:100084. [QxMD MEDLINE Link]. [Full Text].

Eric M Sieloff, MD Academic Chief Fellow, Department of Internal Medicine, Division of Gastroenterology, Ascension Providence Hospital, Michigan State University College of Human Medicine

Eric M Sieloff, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Medical Association, American Society for Gastrointestinal Endoscopy, Association of Medical Professionals with Hearing Losses

Disclosure: Nothing to disclose.

Michael H Piper, MD Clinical Assistant Professor, Department of Internal Medicine, Division of Gastroenterology, Wayne State University School of Medicine; Consulting Staff, Digestive Health Associates, PLC

Michael H Piper, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Gastroenterology, American College of Physicians, Michigan State Medical Society

Disclosure: Nothing to disclose.

Burt Cagir, MD, FACS Associate Regional Dean and Professor of Surgery, Geisinger Commonwealth School of Medicine; Director, General Surgery Residency Program, Executive Director, Donald Guthrie Foundation for Research and Education, Guthrie Robert Packer Hospital; Medical Director, Guthrie/RPH Skills and Simulation Lab; Associate in Surgery, Guthrie Robert Packer Hospital and Corning Hospital

Burt Cagir, MD, FACS is a member of the following medical societies: American College of Surgeons, Association of Program Directors in Surgery, Society for Surgery of the Alimentary Tract

Disclosure: Nothing to disclose.

Hisham Nazer, MBBCh, FRCP, DTM&H Professor of Pediatrics, Consultant in Pediatric Gastroenterology, Hepatology and Clinical Nutrition, University of Jordan Faculty of Medicine, Jordan

Hisham Nazer, MBBCh, FRCP, DTM&H is a member of the following medical societies: American Association for Physician Leadership, Royal College of Paediatrics and Child Health, Royal College of Surgeons in Ireland, Royal Society of Tropical Medicine and Hygiene, Royal College of Physicians and Surgeons of the United Kingdom

Disclosure: Nothing to disclose.

Manoop S Bhutani, MD Professor, Co-Director, Center for Endoscopic Research, Training and Innovation (CERTAIN), Director, Center for Endoscopic Ultrasound, Department of Medicine, Division of Gastroenterology, University of Texas Medical Branch; Director, Endoscopic Research and Development, The University of Texas MD Anderson Cancer Center

Manoop S Bhutani, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Institute of Ultrasound in Medicine, and American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Brooks D Cash, MD, FACP Director of Clinical Research, Assistant Professor of Medicine, Division of Gastroenterology, National Naval Medical Center

Brooks D Cash, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Steven C Dronen, MD, FAAEM Chair, Department of Emergency Medicine, LeConte Medical Center

Steven C Dronen, MD, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Michelle Ervin, MD Chair, Department of Emergency Medicine, Howard University Hospital

Michelle Ervin, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, National Medical Association, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Glenn Fennelly, MD, MPH Director, Division of Infectious Diseases, Lewis M Fraad Department of Pediatrics, Jacobi Medical Center; Clinical Associate Professor of Pediatrics, Albert Einstein College of Medicine

Glenn Fennelly, MD, MPH is a member of the following medical societies: Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Murat Hökelek, MD, PhD Technical Consultant of Parasitology Laboratory, Professor, Department of Clinical Microbiology, Ondokuz Mayis University Medical School, Turkey

Murat Hökelek, MD, PhD is a member of the following medical societies: Turkish Society for Parasitology

Disclosure: Nothing to disclose.

Mark H Johnston, MD Associate Professor of Medicine, Uniformed Services University of Health Sciences; Consulting Staff, Lancaster Gastroenterology Inc

Mark H Johnston, MD is a member of the following medical societies: American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, and Christian Medical & Dental Society

Disclosure: Nothing to disclose.

Sandeep Mukherjee, MB, BCh, MPH, FRCPC Associate Professor, Department of Internal Medicine, Section of Gastroenterology and Hepatology, University of Nebraska Medical Center; Consulting Staff, Section of Gastroenterology and Hepatology, Veteran Affairs Medical Center

Sandeep Mukherjee, MB, BCh, MPH, FRCPC is a member of the following medical societies: Royal College of Physicians and Surgeons of Canada

Disclosure: Merck Honoraria Speaking and teaching; Ikaria Pharmaceuticals Honoraria Board membership

Michael D Nissen, MBBS, FRACP, FRCPA Associate Professor in Biomolecular, Biomedical Science & Health, Griffith University; Director of Infectious Diseases and Unit Head of Queensland Paediatric Infectious Laboratory, Sir Albert Sakzewski Viral Research Centre, Royal Children's Hospital

Michael D Nissen, MBBS, FRACP, FRCPA is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Pediatric Infectious Diseases Society, Royal Australasian College of Physicians, and Royal College of Pathologists of Australasia

Disclosure: Nothing to disclose.

Andre Pennardt, MD, FACEP, FAAEM, FAWM Clinical Associate Professor of Emergency Medicine, Medical College of Georgia; Assistant Professor of Military and Emergency Medicine, Uniformed Services University of the Health Sciences; Consulting Staff, Departments of Emergency Medicine, Aviation Medicine and Dive Medicine, Womack Army Medical Center

Andre Pennardt, MD, FACEP, FAAEM, FAWM is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, Association of Military Surgeons of the US, International Society for Mountain Medicine, National Association of EMS Physicians, Special Operations Medical Association, and Wilderness Medical Society

Disclosure: Nothing to disclose.

Barry J Sheridan, DO Chief Warrior in Transition Services, Brooke Army Medical Center

Barry J Sheridan, DO is a member of the following medical societies: American Academy of Emergency Medicine

Disclosure: Nothing to disclose.

Russell W Steele, MD Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

What would you like to print?

• Print this section
• Print the entire contents of
• Print the entire contents of article